tetano
Editor, Senior Moderator
Open Forum Infect Dis
. 2021 Feb 4;8(3)
fab049.
doi: 10.1093/ofid/ofab049. eCollection 2021 Mar.
Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center
Michele Spinicci[SUP] 1 2 [/SUP], Iacopo Vellere[SUP] 1 [/SUP], Lucia Graziani[SUP] 1 [/SUP], Marta Tilli[SUP] 1 [/SUP], Beatrice Borchi[SUP] 2 [/SUP], Jessica Mencarini[SUP] 2 [/SUP], Irene Campolmi[SUP] 2 [/SUP], Leonardo Gori[SUP] 1 [/SUP], Laura Rasero[SUP] 3 [/SUP], Francesco Fattirolli[SUP] 1 4 [/SUP], Iacopo Olivotto[SUP] 1 5 [/SUP], Federico Lavorini[SUP] 1 6 [/SUP], Niccolò Marchionni[SUP] 1 6 [/SUP], Lorenzo Zammarchi[SUP] 1 2 [/SUP], Alessandro Bartoloni[SUP] 1 2 [/SUP], Careggi Post-acute COVID-19 Study Group
Collaborators, Affiliations
Abstract
We evaluated 100 postacute coronavirus disease 2019 (COVID-19) patients a median (interquartile range) of 60 (48-67) days after discharge from the Careggi University Hospital, Italy. Eighty-four (84%) had at least 1 persistent symptom, irrespective of COVID-19 severity. A considerable number of hospital readmissions (10%) and/or infectious diseases (14%) during the postdischarge period were reported.
Keywords: COVID-19; SARS-CoV-2; follow-up; long-term; sequelae.
. 2021 Feb 4;8(3)
fab049.doi: 10.1093/ofid/ofab049. eCollection 2021 Mar.
Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center
Michele Spinicci[SUP] 1 2 [/SUP], Iacopo Vellere[SUP] 1 [/SUP], Lucia Graziani[SUP] 1 [/SUP], Marta Tilli[SUP] 1 [/SUP], Beatrice Borchi[SUP] 2 [/SUP], Jessica Mencarini[SUP] 2 [/SUP], Irene Campolmi[SUP] 2 [/SUP], Leonardo Gori[SUP] 1 [/SUP], Laura Rasero[SUP] 3 [/SUP], Francesco Fattirolli[SUP] 1 4 [/SUP], Iacopo Olivotto[SUP] 1 5 [/SUP], Federico Lavorini[SUP] 1 6 [/SUP], Niccolò Marchionni[SUP] 1 6 [/SUP], Lorenzo Zammarchi[SUP] 1 2 [/SUP], Alessandro Bartoloni[SUP] 1 2 [/SUP], Careggi Post-acute COVID-19 Study Group
Collaborators, Affiliations
- PMID: 34109256
- PMCID: PMC7928559
- DOI: 10.1093/ofid/ofab049
Abstract
We evaluated 100 postacute coronavirus disease 2019 (COVID-19) patients a median (interquartile range) of 60 (48-67) days after discharge from the Careggi University Hospital, Italy. Eighty-four (84%) had at least 1 persistent symptom, irrespective of COVID-19 severity. A considerable number of hospital readmissions (10%) and/or infectious diseases (14%) during the postdischarge period were reported.
Keywords: COVID-19; SARS-CoV-2; follow-up; long-term; sequelae.